A phase II study evaluating the efficacy of niraparib and dostarlimab (TSR-042) in recurrent/metastatic head and neck squamous cell carcinoma
Karivedu, Vidhya, Riaz, Muhammad Kashif, Mathews, Maria, Kurtzweil, Nicky, Monroe, Ilaina, Romano, Audrey, Wise-Draper, Trisha Michel
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Utilizing molecular resonance-localized surface plasmon resonance coupling for copper ion detection in plasma
Cary, ReJeana, Unser, Sarah, Monroe, Ilaina, Holbrook, Joseph, Sagle, Laura
Published in Analyst (London) (21.07.2020)
Published in Analyst (London) (21.07.2020)
Get full text
Journal Article
Phase II study evaluating the efficacy of niraparib and dostarlimab (TSR-042) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) patients
Zamulko, Olga, Karivedu, Vidhya, Riaz, Muhammad Kashif, Monroe, Ilaina, Romano, Audrey, Mulanda, Rachel, Kurtzweil, Nicky, Forsythe, Allison, Allen, Casey, Harun, Nusrat, Wise-Draper, Trisha M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial
Gulati, Shuchi, Crist, McKenzie, Riaz, Muhammed Kashif, Takiar, Vinita, Lehn, Maria, Monroe, Ilaina, Palackdharry, Sarah, Kurtzweil, Nicky, Jandarov, Roman, Harun, Nusrat, Wise-Draper, Trisha M
Published in Clinical cancer research (15.05.2023)
Published in Clinical cancer research (15.05.2023)
Get full text
Journal Article